Alltop RSS: Ablynx regains nanobody rights from Pfizer

Alltop RSS Alltop RSS feed for pregnancy.alltop.com

Ablynx regains nanobody rights from Pfizer Nov 4th 2011, 08:10 Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which form the basis of a rheumatoid arthritis drug currently undergoing clinical trials.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions